Capital Change Notice

Section 1: Issuer information
Name of issuer Rua Bioscience Limited
NZX ticker code RUA
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website) NZRUAE0004S1
Currency NZD
Section 2: Capital change details
Number issued 250,366
Nominal value (if any) Not applicable
Issue price per security Not applicable
Nature of the payment (for example, cash or other
consideration)
Services provided by those
employees and executive
director who participated in the
employee share bonus offer.
Amount paid up (if not in full) Not applicable
Percentage of total class of Financial Products issued
(calculated on the number of Financial Products of the Class,
excluding any Treasury Stock, in existence)
1

0.179%
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
Not applicable
Reason for issue and specific authority for issue (the reason
for change must be identified here)
Issue of ordinary shares to
those employees and
executive director who
participated in the employee
share bonus offer.
Total number of Financial Products of the Class after the issue
(excluding Treasury Stock) and the total number of Financial
Products of the Class held as Treasury Stock after the issue.
140,262,591
In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
Not applicable
Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
Board resolutions dated 12
November 2020. The ordinary
shares were issued in
accordance with Listing Rule
4.6.

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
The ordinary shares will rank
equally in all respects with
existing ordinary shares in Rua
Bioscience Limited at the date
on which they were issued.
Date of issue
2
13 November 2020
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement
Rob Mitchell, Chief Executive
Officer of Rua Bioscience
Limited
Contact person for this announcement Kerry Donovan
Contact phone number +64 9 309 5840
Contact email address Kerry.donovan@ruabio.com
Date of release through MAP

13 November 2020




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).